Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine vs Tacrolimus for Chronic Ocular GVHD
NCT05294666Phase 4Completed
- Sponsor
- Peking University Third Hospital
- Start
- Apr 2020
- Primary completion
- Jun 2021
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine 2% ophthalmic solution, tacrolimus in chronic ocular graft-versus-host disease (oGVHD), sponsored by Peking University Third Hospital. Started Apr 2020; status: completed.
02
Drugs
cyclosporine 2% ophthalmic solutiontacrolimus
03
Conditions
chronic ocular graft-versus-host disease (oGVHD)
Beyond the preview
Go deeper on NCT05294666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05294666.